Breaking News
Get 50% Off 0
🏄 Grow your portfolio even on vacation with InvestingPro | Summer Sale 50% OFF
CLAIM SALE
Close

Hangzhou Jiuyuan Gene Engineering Co Ltd (2566)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
10.90 -0.05    -0.46%
- Closed. Currency in HKD
Type:  Equity
Market:  Hong Kong
ISIN:  CNE100006KF0 
  • Volume: 539,800
  • Bid/Ask: 10.90 / 10.91
  • Day's Range: 10.74 - 11.26
Hangzhou Jiuyuan Gene Engineering 10.90 -0.05 -0.46%

Hangzhou Jiuyuan Gene Engineering Co Ltd Company Profile

 
Get an in-depth profile of Hangzhou Jiuyuan Gene Engineering Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

1541

Equity Type

ORD

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of biopharmaceutical products and medical devices. The company offers Guyoudao, a recombinant human bone morphogenetic protein-2 bone repair product; Jilifen, a human granulocyte colony-stimulating factor injection for neutropenia; Jijufen, a human interleukin-11 injection for chemotherapy-induced thrombocytopenia; and Jiouting, a palonosetron hydrochloride injection for nausea and vomiting induced by radiation therapy, chemotherapy, or postoperative conditions. It also provides Jifuwei, a fulvestrant injection for advanced breast cancer; Jitansu, a fosaprepitant dimeglumine injection for chemotherapy-induced nausea and vomiting; Jixinfen, a polyethylene glycol-modified human granulocyte colony-stimulating factor injection for neutropenia; Jipailin, a low molecular weight heparin sodium injection for venous thromboembolic diseases; and Yinuojia, an enoxaparin sodium injection for venous thromboembolic diseases. The company was formerly known as Hangzhou Jiuyuan Gene Engineering Co., Ltd. and changed its name to Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. in April 2025. Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. was incorporated in 1993 and is headquartered in Hangzhou, China.

Contact Information

Address No. 23, Eighth Street Baiyang Street
Qiantang District Hangzhou,
China
Phone 86 571 8687 9123
Fax 86 571 8691 1688

Top Executives

Name Age Since Title
Shihang Wu 34 2021 Non-executive Director
Feihu Xu 47 2023 Supervisor
Junjie Fei 28 2023 Non-executive Director
Zhou Wei 49 2019 Deputy GM, GM of Pharmacy Services & Executive Director
Honglan Ma 54 2021 Non-executive Director
Mei Yi Ho 58 2023 Independent Non-Executive Director
Hang Fu 62 2000 Executive Chairman & GM
Jiancai Ye 55 2023 Chairman of the Supervisory Committee
Fei Zhao 37 2023 Employee Representative Supervisor
Zhihu Zhou 44 2023 Independent Non-Executive Director
Albert Esteve Cruella 66 2007 Non-executive Director
Demin Zhou 58 2023 Independent Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

2566 Comments

Write your thoughts about Hangzhou Jiuyuan Gene Engineering Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email